Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge

Vaccine

Volumn 25, Issue 41, 2007, Pages 7238-7246

  Miller, Patti J ^a   King, Daniel J ^a   Afonso, Claudio L ^a   Suarez, David L ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Exotic Newcastle disease; Immunity; Vaccine

Indexed keywords

NEWCASTLE DISEASE VACCINE;

AMNION FLUID; ANIMAL EXPERIMENT; ARTICLE; BIRD; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; DRUG FORMULATION; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEMAGGLUTINATION; MORBIDITY; MORTALITY; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOME, VIRAL; GENOTYPE; HEMAGGLUTINATION INHIBITION TESTS; MOLECULAR SEQUENCE DATA; MOUTH; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SPECIFIC PATHOGEN-FREE ORGANISMS; SURVIVAL ANALYSIS; VIRAL PROTEINS; VIRAL VACCINES; VIRUS SHEDDING;

EID: 34648846704     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.017     Document Type: Article

References (52)

1. Mayo M.A. A summary of taxonomic changes recently approved by ICTV. Arch Virol 147 8 (2002) 1655-1663
2. Alexander D.J. Newcastle disease, other avian paramyxoviruses, and pneumovirus infections. In: Saif J.M., Barnes H.J., Glisson J.R., Fadly A.M., McDougald L.R., and Swayne D.E. (Eds). Diseases of poultry. 11th ed. (2003), Iowa State University Press, Ames 63-99
3. Seal B.S., King D.J., and Sellers H.S. The avian response to Newcastle disease virus. Dev Comp Immunol 24 2-3 (2000) 257-268
4. Alexander D.J., Morris H.T., Pollitt W.J., Sharpe C.E., Eckford R.L., Sainsbury R.M., et al. Newcastle disease outbreaks in domestic fowl and turkeys in Great Britain during 1997. Vet Rec 143 8 (1998) 209-212
5. Aldous E.W., Mynn J.K., Banks J., and Alexander D.J. A molecular epidemiological study of avian paramyxovirus type 1 (Newcastle disease virus) isolates by phylogenetic analysis of a partial nucleotide sequence of the fusion protein gene. Avian Pathol 32 3 (2003) 239-256
6. Ballagi-Pordany A., Wehmann E., Herczeg J., Belak S., and Lomniczi B. Identification and grouping of Newcastle disease virus strains by restriction site analysis of a region from the F gene. Arch Virol 141 2 (1996) 243-261
7. Czegledi A., Ujvari D., Somogyi E., Wehmann E., Werner O., and Lomniczi B. Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. Virus Res 120 (2006) 36-48
8. Hanson R.P., Crook E., and Brandly C.A. Comparisons of immunogenicity of five strains of Newcastle disease virus as formalinized vaccines. Vet Med 46 (1951) 451-452
9. USDA. The Office of the Federal Register National Archives and Records Administration Code of Federal Regulations. Title 9 Animals and Animal Products: Chapter I APHIS, Department of Agriculture; Part 94; 2006, p. 490.
10. Kapczynski D.R., and King D.J. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine 23 26 (2005) 3424-3433
11. Senne D.A., King D.J., and Kapczynski D.R. Control of Newcastle disease by vaccination. Dev Biol (Basel) 119 (2004) 165-170
12. Butterfield W.K., Dardiri A.H., and Yedloutschnig R.J. Protection of chickens afforded by commercial lentogenic vaccines against challenge exposure to velogenic Newcastle disease virus. Avian Dis 17 2 (1973) 279-282
13. Benson H.N., Wenger D.R., and Beard P.D. Efficacy of a commercial Newcastle vaccine against velogenic viscerotropic Newcastle disease virus. Avian Dis 19 3 (1975) 566-572
14. Beard C.W., Villegas P., and Glisson J.R. Comparative efficacy of the B-1 and VG/GA vaccine strains against velogenic viscerotropic Newcastle disease virus in chickens. Avian Dis 37 1 (1993) 222-225
15. Upton E., Hanson R.P., and Brandly C.A. Antigenic differences among strains of Newcastle disease virus. Proc Soc Exp Biol Med 84 3 (1953) 691-693
16. Spalatin J., and Hanson R.P. Comparison of B1 and Ulster strains of Newcastle disease virus as vaccines against the viscerotropic form of disease. Proceedings of the 21st Western poultry disease conference and 6th poultry health symposium (1972) 66-69
17. King D.J. Avian paramyxovirus type 1 from pigeons: isolate characterization and pathogenicity after chicken or embryo passage of selected isolates. Avian Dis 40 3 (1996) 707-714
18. Kim L.M., King D.J., Suarez D.L., Wong C.W., and Afonso C.L. Characterization of Class I Newcastle disease virus isolates from Hong Kong bird markets and detection using real-time reverse transcription PCR. J Clin Microbiol 45 4 (2007) 1310-1314
19. Wakamatsu N., King D.J., Kapczynski D.R., Seal B.S., and Brown C.C. Experimental pathogenesis for chickens, turkeys, and pigeons of exotic Newcastle disease virus from an outbreak in California during 2002-2003. Vet Pathol 43 6 (2006) 925-933
20. Kommers G.D., King D.J., Seal B.S., and Brown C.C. Virulence of pigeon-origin Newcastle disease virus isolates for domestic chickens. Avian Dis 45 4 (2001) 906-921
21. Alexander D.J., Campbell G., Manvell R.J., Collins M.S., Parsons G., and McNulty M.S. Characterisation of an antigenically unusual virus responsible for two outbreaks of Newcastle disease in the Republic of Ireland in 1990. Vet Rec 130 4 (1992) 65-68
22. Thayer S.G., and Beard C.W. Serological procedures. In: Swayne D.E. (Ed). A laboratory manual for the isolation and identification of avian pathogens. 4th ed. (1998), American Association of Avian Pathologists, Kennett Square 255-266
23. Spradbrow P.B., and Samuel J.L. Oral Newcastle disease vaccination with V4 virus in chickens: comparison with other routes. Aust Vet J 68 3 (1991) 114-115
24. Alexander D.J. Newcastle disease virus and other avian paramyxoviruses. In: Swayne D.E., Glisson J.R., Jackwood M.W., Pearson J.E., and Reed W.M. (Eds). A laboratory manual for the isolation and identification of avian pathogens. 4th ed. (1998), American Association of Avian Pathologists, Kennett Square 156-163
25. Budowsky E.I., Smirnov Yu.A., and Shenderovich S.F. Principles of selective inactivation of viral genome. VIII. The influence of beta-propiolactone on immunogenic and protective activities of influenza virus. Vaccine 11 3 (1993) 343-348
26. Stone H.D., Brugh M., and Beard C.W. Influence of formulation on the efficacy of experimental oil-emulsion Newcastle disease vaccines. Avian Dis 27 (1983) 688-697
27. Stone H.D., Brugh M., Hopkins S.R., Yoder H.W., and Beard C.W. Preparation of inactivated oil-emulsion vaccines with avian viral or Mycoplasma antigens. Avian Dis 22 4 (1978) 666-674
28. King D.J. Influence of chicken breed on pathogenicity evaluation of velogenic neurotropic Newcastle disease virus isolates from cormorants and turkeys. Avian Dis 40 1 (1996) 210-217
29. Kommers G.D., King D.J., Seal B.S., and Brown C.C. Pathogenesis of chicken-passaged Newcastle disease viruses isolated from chickens and wild and exotic birds. Avian Dis 47 2 (2003) 319-329
30. International Office of Epizootics. Biological Standards Commission. Manual of diagnostic tests and vaccines for terrestrial animals: mammals, birds and bees. 5th ed. (2004), Office international des âepizooties, Paris
31. Kim L.M., Afonso C.L., and Suarez D.L. Effect of probe-site mismatches on detection of virulent Newcastle disease viruses using a fusion-gene real-time reverse transcription polymerase chain reaction test. J Vet Diagn Invest 18 6 (2006) 519-528
32. Lipman D.J., and Pearson W.R. Rapid and sensitive protein similarity searches. Science 227 4693 (1985) 1435-1441
33. Guindon S., Lethiec F., Duroux P., and Gascuel O. PHYML Online-a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res 33 Web Server issue (2005) W557-W559
34. Reynolds D.L., and Maraqa A.D. Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides. Avian Dis 44 1 (2000) 138-144
35. Merz D.C., Scheid A., and Choppin P.W. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med 151 2 (1980) 275-288
36. Boursnell M.E., Green P.F., Samson A.C., Campbell J.I., Deuter A., Peters R.W., et al. A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology 178 1 (1990) 297-300
37. Boursnell M.E., Green P.F., Campbell J.I., Deuter A., Peters R.W., Tomley F.M., et al. A fowlpox virus vaccine vector with insertion sites in the terminal repeats: demonstration of its efficacy using the fusion gene of Newcastle disease virus. Vet Microbiol 23 1-4 (1990) 305-316
38. Kamiya N., Niikura M., Ono M., Kai C., Matsuura Y., and Mikami T. Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective efficacy. Virus Res 32 3 (1994) 373-379
39. Loke C.F., Omar A.R., Raha A.R., and Yusoff K. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. Vet Immunol Immunopathol 106 3-4 (2005) 259-267
40. Park M.S., Steel J., Garcia-Sastre A., Swayne D., and Palese P. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci USA 103 21 (2006) 8203-8208
41. Umino Y., Kohama T., Kohase M., Sugiura A., Klenk H.D., and Rott R. Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus. Arch Virol 81 1-2 (1984) 53-65
42. Pedersen J.C., Senne D.A., Woolcock P.R., Kinde H., King D.J., Wise M.G., et al. Phylogenetic relationships among virulent Newcastle disease virus isolates from the 2002-2003 outbreak in California and other recent outbreaks in North America. J Clin Microbiol 42 5 (2004) 2329-2334
43. Kendal A.P., and Allan A.W. Comparative studies of Newcastle disease viruses: virulence, antigenic specificity, and growth kinetics. Microbios 2 7-8 (1970) 273-284
44. Taylor J., Weinberg R., Kawaoka Y., Webster R.G., and Paoletti E. Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 6 6 (1988) 504-508
45. Webster R.G., Taylor J., Pearson J., Rivera E., and Paoletti E. Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant. Avian Dis 40 2 (1996) 461-465
46. Swayne D.E., Beck J.R., and Mickle T.R. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Dis 41 4 (1997) 910-922
47. Swayne D., Beck J.R., Garcia M., and Stone H.D. Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines. Avian Pathol 28 3 (1999) 245-256
48. Swayne D.E., Garcia M., Beck J.R., Kinney N., and Suarez D.L. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18 11-12 (2000) 1088-1095
49. Seal B.S., King D.J., and Meinersmann R.J. Molecular evolution of the Newcastle disease virus matrix protein gene and phylogenetic relationships among the paramyxoviridae. Virus Res 66 1 (2000) 1-11
50. Toyoda T., Sakaguchi T., Hirota H., Gotoh B., Kuma K., Miyata T., et al. Newcastle disease virus evolution. II. Lack of gene recombination in generating virulent and avirulent strains. Virology 169 2 (1989) 273-282
51. Lee C.W., Senne D.A., and Suarez D.L. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 78 15 (2004) 8372-8381
52. Marangon S., and Capua I. Control of avian influenza in Italy: from stamping out to emergency and prophylactic vaccination. Dev Biol (Basel) 124 (2006) 109-115